Compare Goodyear Tire & Rubber Co (GT) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goodyear Tire & Rubber Co vs BIO-TECHNE Corp — how do they compare? Goodyear Tire & Rubber Co trades at $4.78 (market cap $1.35B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: BIO-TECHNE Corp is far larger — about 8.4× Goodyear Tire & Rubber Co's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Goodyear Tire & Rubber Co pays none. Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 57 Days and BIO-TECHNE Corp for 63 Days on average.
| GT | TECH | |
|---|---|---|
Market Cap | $1.35B | $11.37B |
Volume | 6,504,242 | 3,153,511 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $72.61 |
52-Week Low | $4.66 | $43.31 |
Typical Hold Time | 57 Days | 63 Days |
Enterprise Value | $8.70B | $11.40B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The Goodyear Tire & Rubber Company (GT) trades at $4.69, near its 52-week low, with a bearish technical signal and mixed earnings history. Despite beating EPS estimates in two recent quarters, the company reported a net loss of $1.72 billion in 2025, with negative profit margins and ROE. Cash flow improved slightly in 2025, but high debt levels and declining revenue pose challenges. Recent news highlights restructuring efforts and a 'shrink-to-grow' strategy targeting premium tire segments.
GT presents a high-risk opportunity with a deep value proposition—low P/E and P/B ratios suggest undervaluation, but persistent losses and bearish analyst sentiment indicate significant headwinds. The stock's upside hinges on successful execution of its turnaround plan and margin improvement, while downside risks include ongoing volume pressure and macroeconomic pressures on the auto industry.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Goodyear Tire & Rubber Co
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
